Amgen, Inc. (AMGN)
375.82
-8.50
(-2.21%)
USD |
NASDAQ |
Feb 09, 16:00
374.23
-1.59
(-0.42%)
After-Hours: 06:36
Amgen Market Cap : 202.57B for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 188.19B |
| Johnson & Johnson | 574.95B |
| Eli Lilly & Co. | 935.00B |
| Merck & Co., Inc. | 292.01B |
| Regeneron Pharmaceuticals, Inc. | 82.49B |
Market Cap Related Metrics
| PE Ratio | 26.41 |
| PS Ratio | 5.546 |
| PEG Ratio | 0.2983 |
| Price to Book Value | 23.40 |
| Price to Free Cash Flow | 20.45 |
| Price | 375.82 |
| Earnings Yield | 3.79% |
| PEGY Ratio | 0.29 |
| Operating PE Ratio | 19.86 |